Free Cash Flow

International Petroleum Corp. is ahead of schedule and on budget at its massive Blackrod oil sands project, signaling a major win for Canadian energy.

CEO Eric Hambly will face investors at a key conference, balancing oil production strategy with the rising tide of clean technology and decarbonization.

Investors eye Hexcel's Q4 2025 results for signs of an aerospace rebound, strategic shifts under new leadership, and the future of advanced composites.

Genelux appoints Dr. Jason Litten as CMO, a strategic move to steer its promising oncolytic virus, Olvi-Vec, through crucial late-stage cancer trials.

With patent cliffs looming and big bets on M&A, all eyes are on BMS to prove its growth strategy and high-stakes pipeline can deliver in 2026.

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

Bitcoin miner Bitfarms sells its last Latin American asset for $30M, pivoting fully to the booming North American AI and HPC infrastructure market.

Aeromexico repeats as the world's most on-time airline, while Qatar Airways earns top honors for operational excellence in Cirium's 2025 rankings.

Intelligent Bio Solutions raised crucial capital for its fingerprint drug test, but the deal's structure sent shares tumbling amid shareholder dilution fears.

Interim CFO Donna Granato's departure marks a pivotal moment for Ayr Wellness as it completes a massive debt restructuring and transitions to a new entity.

As Wesdome Gold Mines targets mid-tier status, the appointment of financial expert Faheem Tejani signals a strategic move to bolster financial oversight.

INVO Fertility realigns its top brass, positioning a deal-making veteran to lead an aggressive clinic acquisition strategy in a booming market.

Amid market volatility and a green energy push, Devon's CEO will outline the firm's strategy for navigating a complex 2026 at a top industry event.

Amid economic headwinds, the M&A advisor thrived by securing over 90 deals and promoting key partners, signaling strong momentum for healthcare sales in 2026.

Riding a wave of record revenue and a favorable reimbursement outlook, iRhythm's upcoming JPM presentation is a key test for its 2026 growth strategy.

As CooperCompanies heads to the J.P. Morgan conference, all eyes are on CEO Al White's strategic vision for its dual vision and women's health units.

After eliminating over $10.7M in debt, cannabis operator LEEF Brands leverages strong Q3 growth to fuel major expansion in California and New York.

With soaring revenue and a landmark FDA approval for its Shield cancer test, Guardant Health's upcoming JPM presentation is poised to define its future.

A new report details how interconnected apps, wearables, and AI are creating a 'Human Performance Economy' that extends far beyond the gym's walls.

After a swift restructuring, Modivcare emerges debt-light and privately owned, poised to aggressively invest in technology and transform supportive care.